INVESTOR PRESENTATION AVAILABILITY NOTICE: FULL YEAR 2022

Verdellino (BG), 3 April 2023

Fine Foods FULL YEAR publicly available on www.finefoods.it, in the Investor relations / Presentationssection.

***

This press release is available on the Fine Foods website www.finefoods.it,in the Investor Relations/Press Releases section.

***

independent CDMO (Contract Development and Manufacturing Organisation) that develops and manufactures contract products for the pharmaceutical, nutraceutical, cosmetics, biocides and medical devices industries. Founded in 1984, Fine Foods proved to be a re organisation can provide successful design process and solid, long-term partnerships. The continuous search for d includes research and development, innovation, process reliability, product quality, ESG, and sustainable management of the Group's supply chain. Fine Foods is a benefit corporation which relies on certifications and ratings under international standards. These guarantee its sustainability 207 million revenue in 2022 and more than an 10 per cent CAGR over the last decade, Fine Foods is a growing and future-oriented company.

***

For further information:

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Tel +39 035 4821382

Investor Relations: ir@finefoods.it

Media Relations: media.relations@finefoods.it

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Via Berlino, 39 Zingonia-Verdellino 24040 (BG) Italia

CF / P.IVA IT 09320600969

FINEFOODS.IT

T. +39 035 4821382 info@finefoods.it

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Fine Foods & Pharmaceuticals NTM S.p.A. published this content on 03 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 April 2023 08:48:06 UTC.